Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Mar 22 2001
The Biotechnology Industry Organization ("BIO") is pleased to have the opportunity to submit testimony expressing our concerns about the federal...
Mar 13 2001
Reporters urged to register now! WASHINGTON, D.C. (March 13, 2001) – The Biotechnology Industry Organization (BIO) today announced that the preliminary program...
Mar 7 2001
WASHINGTON, D.C. (March 7, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following the Environmental Protection...
Mar 6 2001
Washington, D.C. (March 6, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following Senate introduction of a bill...
Mar 1 2001
Washington, D.C. (March 1, 2001) -- The Biotechnology Industry Organization (BIO) will begin a six month television advertising campaign this weekend on both...
Feb 22 2001
WASHINGTON, DC (February 22, 2001) --Michael J. Werner, director of federal government relations and bioethics counsel for the Biotechnology Industry...
Feb 16 2001
Washington, D.C. – A record 32 biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug Administration...
Feb 15 2001
WASHINGTON, D.C. (February 15, 2001) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
Feb 14 2001
WASHINGTON, D.C. (February 14, 2001) – U.S. Sen. Tim Hutchinson (R-Arkansas) and Newt Gingrich, former Speaker of the U.S. House of Representatives, will be...


Biotechnology News

September 1, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate announced the appointment of Alex Karle to the role of Chief Executive Officer. Dr Jonathan de Pass, founder and...

September 1, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of...

September 1, 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (...

September 1, 2014

MUNICH--(BUSINESS WIRE)--Diaverum, one of the world’s leading renal care providers today announced changes to its Executive Team and its underlying area structure. The...